Dalhousie enters world’s top 20 per cent in latest QS World University Rankings
Dalhousie rose to the top 20 per cent in the 2024 QS World University Rankings, which this year included institutions from 104 countries around the world.
The upside of volatile space weather
Although violent and unpredictable, stellar flares emitted by a planet’s host star do not necessarily prevent life from forming, according to a new Northwestern University study.
Celebrated Southampton professor elected British Academy fellow
A professor of social and political philosophy at the University of Southampton has been named a fellow of the British Academy in recognition of his contribution to humanities and social sciences.
University of Alberta virologist awarded Nobel Prize in Physiology or Medicine
Michael Houghton was awarded the 2020 Nobel Prize in Physiology or Medicine today in recognition of his discovery of the hepatitis C (HCV) virus.
Four Massey projects awarded funding to further health research
Four Massey-led research projects have been awarded Health Delivery Grants from the Health Research Council.
Funding boost means sunny days for solar innovation
A $4.5 million funding boost will help researchers at The Australian National University (ANU) develop next-generation solar cell technology.
Southampton at heart of UK’s plans to become AI powerhouse
The future of “safe and trustworthy” artificial intelligence will be led from Southampton – a professor behind a new multimillion AI institute launched in the city has revealed.
Global demand for cancer surgery set to surge
A new modelling study led by UNSW predicts demand for cancer surgery will rise by 52 per cent within two decades, with low-income countries bearing the greatest burden.
New funding for UofG-led quantum technologies research alliance
The University of Glasgow is set to play host to a third new collaborative research alliance supported by the Scottish Funding Council (SFC).
Oxford University breakthrough on global COVID-19 vaccine
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019...
- Advertisement -
